CureVac
CureVac's Overview
CureVac is a global biopharmaceutical company with over 20 years of expertise in developing and optimizing the versatile messenger RNA (mRNA) platform. The company's vision is to revolutionize medicine and create a new class of transformative medicines. CureVac focuses on developing prophylactic vaccines, cancer therapies, antibody therapies, and treatments for rare diseases. Their proprietary RNAoptimizer® platform aims to optimize the properties of mRNA therapeutics and vaccines.
Where is CureVac's Headquarters?
HQ Function
Central hub for R&D, corporate operations, and strategic management; birthplace of CureVac's mRNA technology platform.
Notable Features:
Located in the Tübingen Technology Park, the headquarters includes advanced laboratories and state-of-the-art GMP (Good Manufacturing Practice) production facilities to support clinical trials and potential commercialization.
Work Culture:
The work culture at CureVac's Tübingen headquarters is characterized by scientific rigor, innovation, a collaborative spirit, and a strong focus on cutting-edge mRNA research. Employees are driven by the potential global health impact of their work.
HQ Significance:
Tübingen is strategically important for CureVac due to its strong academic and research environment, facilitating talent acquisition and collaborations. It is the company's founding location where its core technological expertise has been developed.
Values Reflected in HQ: The headquarters' focus on advanced research facilities and expansion for manufacturing reflects CureVac's commitment to innovation, scientific excellence, and its mission to bring mRNA-based medicines to patients worldwide.
Location:
CureVac operates primarily from its headquarters in Tübingen, Germany, with significant sites in Boston, USA, and Frankfurt, Germany. Its global functions include research and development, multi-regional clinical trials, manufacturing (primarily in Germany), and collaborations with pharmaceutical partners worldwide. The company's mRNA technology platform is being developed for global health applications, addressing infectious diseases and oncology on an international scale.
Street Address:
Friedrich-Miescher-Strasse 15
City:
Tübingen
State/Province:
Baden-Württemberg
Country:
Germany
CureVac's Global Presence
Burlington, Massachusetts, USA
Address: 3 Burlington Woods Drive, Suite 102, Burlington, MA 01803, USA
To advance CureVac's clinical trial programs in the U.S., engage with U.S. regulatory authorities like the FDA, and foster partnerships within the North American pharmaceutical and biotech industry.
Frankfurt am Main, Germany
Address: Specific street address not widely publicized; supports business/corporate functions.
To facilitate corporate activities, engage with the financial community, and support CureVac's operational network within Germany.
Buying Intent Signals for CureVac
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of CureVac
As of April 2025, CureVac' leadership includes:
Investors of CureVac
CureVac has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
CureVac has undergone significant leadership transitions in the past 12 months (approx. mid-2023 to mid-2024), including the appointment of a new CEO, Dr. Alexander Zehnder, a new CBO, Thaminda Ramanayake, and a new CDO, Dr. Myriam Mendila. These appointments followed departures of the former CEO and other C-suite members as part of strategic realignments.
Departures
New Appointments:
Technology (Tech Stack) used by CureVac
Discover the tools CureVac uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
CureVac Email Formats and Examples
CureVac generally utilizes a standard corporate email format, typically combining an employee's first and last name with the company domain. This is a common pattern for professional communication.
[first].[last]@curevac.com
Format
jane.doe@curevac.com
Example
85%
Success rate
News and media
GlobeNewswire (CureVac Press Release) • June 6, 2024
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program
CureVac reported encouraging interim data from its Phase 2 study of monovalent and bivalent COVID-19 vaccine candidates developed in collaboration with GSK. The data showed good tolerability and immunogenicity, supporting progression to a Phase 3 study....more
GlobeNewswire (CureVac Press Release) • May 15, 2024
CureVac Reports First Quarter 2024 Financial Results and Business Updates
CureVac provided an update on its financial performance for Q1 2024 and highlighted progress in its clinical pipeline, including advancements in its seasonal flu and COVID-19 vaccine programs in collaboration with GSK, and its oncology programs....more
GlobeNewswire (CureVac Press Release) • April 25, 2024
CureVac Announces Publication of Preclinical Data Demonstrating Broad Protective Efficacy of Influenza Vaccine Candidate
CureVac announced the publication of preclinical data in Nature Communications showcasing the potent and broad protective efficacy of its multivalent influenza vaccine candidate, co-developed with GSK. The mRNA-based vaccine demonstrated protection against multiple influenza strains....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including CureVac, are just a search away.